federal_register: 03-32100
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| document_number | title | type | abstract | publication_date | pub_year | pub_month | html_url | pdf_url | agency_names | agency_ids | excerpts |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 03-32100 | Pediculicide Drug Products for Over-the-Counter Human Use; Amendment of Final Monograph | Rule | The Food and Drug Administration (FDA) is issuing a final rule amending the final monograph (FM) for over-the-counter (OTC) pediculicide drug products to revise labeling for the statement of identity, warnings, directions, and other required statements. Pediculicide drug products are used for the treatment of head, pubic (crab), and body lice. FDA is issuing this final rule as part of its ongoing review of OTC drug products after considering public comment on its proposed regulation and all relevant data and information that have come to the agency's attention. | 2003-12-31 | 2003 | 12 | https://www.federalregister.gov/documents/2003/12/31/03-32100/pediculicide-drug-products-for-over-the-counter-human-use-amendment-of-final-monograph | https://www.govinfo.gov/content/pkg/FR-2003-12-31/pdf/03-32100.pdf | Health and Human Services Department; Food and Drug Administration | 221,199 | The Food and Drug Administration (FDA) is issuing a final rule amending the final monograph (FM) for over-the-counter (OTC) pediculicide drug products to revise labeling for the statement of identity, warnings, directions, and other required... |